Safety Review Committee Data Visualization
Traditional Safety Review Committee workflows often rely on static tables, listings, and PDF review packs, requiring reviewers to cross-check information across adverse events, laboratory data, concomitant medications, dosing, and patient listings. This can make safety review preparation more complex and leave less time for interpreting findings and making timely decisions.
MMS partnered with a clinical-stage biotech to support recurring SRC reviews for a Phase 2a study. Using Datacise® Explore, MMS integrated data from multiple external sources and provided standard and study-specific safety visualizations, statistical support, SRC preparation, project management, and safety reporting.
The result was a shared, interactive review environment that enabled the sponsor and SRC members to move from study-level trends into relevant patient-level detail without relying solely on disconnected reports and listings.
What You’ll Learn
- Discover how integrated safety visualizations can modernize recurring SRC reviews.
- See how connecting multiple clinical data sources creates a more complete view of safety findings.
- Learn how interactive dashboards help reviewers move from study-level trends to patient-level detail.
- Understand how statistical expertise and proactive project management strengthen safety oversight.
- Explore how Datacise® can modernize safety review without requiring a complex standalone platform.
